Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 17, 2026 17:32 ET | Source: NorthStrive Acquisition Corp I.

NorthStrive Acquisition Corp I. Announces Pricing of $100 Million Initial Public Offering

NorthStrive Acquisition Corp I. $100 Million Initial Public Offering
August 14, 2026 16:05 ET | Source: Thunder Bridge Capital Partners V, Ltd.

Thunder Bridge Capital Partners V, Ltd. Announces Closing of $300.15 Million Initial Public Offering, Including Full Exercise of Over-Allotment Option

Great Falls, VA, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Thunder Bridge Capital Partners V, Ltd. (the “Company”) announced today that it closed its initial public offering of 30,015,000 units at $10.00...
August 14, 2026 09:00 ET | Source: YXT.COM GROUP HOLDING LIMITED

YXT.COM GROUP HOLDING Ltd Announces Pricing of $1.5 Million Registered Direct Offering

SUZHOU, China, Aug. 14, 2026 (GLOBE NEWSWIRE) -- YXT.COM GROUP HOLDING Ltd (NASDAQ: YXT) ("YXT.com" or the "Company"), a provider of AI-native enterprise productivity solutions, today announced that...
August 13, 2026 16:01 ET | Source: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an...
August 13, 2026 01:15 ET | Source: Robinhood Markets, Inc.

Robinhood Ventures Fund II (RVII) Announces Pricing of Initial Public Offering

Today, Robinhood Ventures Fund II (RVII) announced the pricing of its initial public offering of 8,000,000 common shares of beneficial interest.
August 11, 2026 20:01 ET | Source: Silexion Therapeutics, Inc.

Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering

GRAND CAYMAN, Cayman Islands, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotechnology company...
August 10, 2026 16:15 ET | Source: OceanLight Acquisition Corporation

OceanLight Acquisition Corporation Announces Closing of Initial Public Offering

NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- OceanLight Acquisition Corporation (Nasdaq: OCLTU, the “Company”) announced today the closing of its initial public offering (“IPO”) of 10,000,000 units...
August 10, 2026 16:05 ET | Source: Ticketplus

Ticketplus Announces Closing of Initial Public Offering

SANTIAGO, Chile and NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Ticketplus Ltd. (“Ticketplus” or the “Company”), a technology company that operates a proprietary, full-stack technology platform...
August 07, 2026 16:30 ET | Source: iSpecimen Inc.

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

WOBURN, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for...
August 07, 2026 15:45 ET | Source: E.F. Hutton & Co.

E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as the exclusive placement...